Alliancebernstein L.P. Selecta Biosciences Inc Transaction History
Alliancebernstein L.P.
- $275 Billion
- Q1 2024
A detailed history of Alliancebernstein L.P. transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 17,280 shares of SELB stock, worth $14,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,280
Previous 17,280
-0.0%
Holding current value
$14,515
Previous $11,000
27.27%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SELB
# of Institutions
68Shares Held
41.4MCall Options Held
16.8KPut Options Held
0-
Artal Group S.A. Luxembourg, N49.14MShares$7.67 Million0.41% of portfolio
-
Black Rock Inc. New York, NY7.25MShares$6.09 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.32MShares$5.3 Million0.0% of portfolio
-
Nano Dimension, Inc.3.79MShares$3.18 Million25.2% of portfolio
-
Geode Capital Management, LLC Boston, MA2.5MShares$2.1 Million0.0% of portfolio
About SELECTA BIOSCIENCES INC
- Ticker SELB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 152,712,992
- Market Cap $128M
- Description
- Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...